These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7513217)

  • 21. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
    Smyth JM; Sheahan BJ; Atkins GJ
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
    Dimmock NJ; Kennedy SI
    J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.
    van Tiel FH; Harmsen T; Wagenaar M; Boere WA; Kraaijeveld CA; Snippe H
    J Clin Microbiol; 1986 Oct; 24(4):665-8. PubMed ID: 3533979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infection of cultured murine brain cells by Semliki Forest virus: effects of interferon-alpha beta on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes.
    Morris A; Tomkins PT; Maudsley DJ; Blackman M
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():99-106. PubMed ID: 3492589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus.
    Smee DF; Alaghamandan HA; Kini GD; Robins RK
    Antiviral Res; 1988 Dec; 10(6):253-62. PubMed ID: 2854956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay of defective-interfering semliki forest virus by the inhibition of synthesis of virus-specified RNAs.
    Barrett AD; Crouch CF; Dimmock NJ
    J Gen Virol; 1981 Jun; 54(Pt 2):273-80. PubMed ID: 6169791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase of interferon antiviral activity by exogenous cyclic adenosine-3':5'-monophosphate (cAMP).
    Koblet H; Wyler R; Kohler U
    Experientia; 1979 May; 35(5):575-6. PubMed ID: 221234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The enhancing effect of copper, nickel, and cobalt ions on plaque formation by Semliki Forest virus (SFV) in chicken embryo fibroblasts.
    Wyler R; Wiesendanger W
    Arch Virol; 1975; 47(1):57-69. PubMed ID: 167680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of in vitro inhibitory potential of type-I interferons and different antiviral compounds on rabies virus replication.
    Marosi A; Forgách P; Gyuranecz M; Sulyok KM; Bakonyi T
    Vaccine; 2019 Aug; 37(33):4663-4672. PubMed ID: 29459063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplication of Semliki forest virus in the tissues of Aedes aegypti cultured in vitro.
    Bidwell DE
    Ann Trop Med Parasitol; 1973 Dec; 67(4):409-17. PubMed ID: 4787713
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of cordycepin on the multiplication of Semliki Forest virus and on polyadenylation of viral RNA.
    Wittek R; Koblet H; Menna A; Wyler R
    Arch Virol; 1977; 54(1-2):95-106. PubMed ID: 302113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid bioassay of human interferon by direct enzyme immunoassay of encephalomyocarditis virus in HEp-2 cell monolayers after a single cycle of infection.
    Vlaspolder F; Donkers E; Harmsen T; Kraaijeveld CA; Snippe H
    J Virol Methods; 1989; 24(1-2):153-8. PubMed ID: 2474560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The kinetics of formation and sensitivity to interferon of viral intermediates appearing in chick cells infected with Semliki Forest virus.
    Mécs I
    Acta Virol; 1973 May; 17(3):177-88. PubMed ID: 4147135
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on interferon induction and interferon sensitivity of avian reoviruses.
    Ellis MN; Eidson CS; Brown J; Kleven SH
    Avian Dis; 1983; 27(4):927-36. PubMed ID: 6197057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of arbovirus protein synthesis by interferon.
    Friedman RM
    J Virol; 1968 Oct; 2(10):1081-5. PubMed ID: 5723711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of alphavirus infection as demonstrated by infection of ECV 304 transformed human umbilical vein capillary endothelial cells with Semliki Forest virus.
    Jakob R
    J Med Microbiol; 1993 Jul; 39(1):26-32. PubMed ID: 8326511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.
    Oosterlaken TA; Harmsen M; Tangerman C; Schielen P; Kraaijeveld CA; Snippe H
    J Immunol Methods; 1988 Dec; 115(2):255-61. PubMed ID: 3058808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effect of interferon preparations and some interferon inducers: activation of adenylate cyclase system.
    Mécs I; Kásler M; Lózsa A; Kovács G
    Acta Microbiol Acad Sci Hung; 1974; 21(3-4):265-8. PubMed ID: 4372863
    [No Abstract]   [Full Text] [Related]  

  • 40. Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies.
    van Tiel FH; Boere WA; Harmsen T; Kraaijeveld CA; Snippe H
    Antimicrob Agents Chemother; 1985 May; 27(5):802-5. PubMed ID: 3925876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.